Stelara 90 MG/ML syringeml

Ended Awarded Last action

Contract number
SPE2DR26FQTC8
Awardee
Awarding agency
Obligated
$16,584

Award facts

Contract value 100% obligated
$16,584.13 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 22, 2026, for Stelara 90 mg/ml syringes with a ceiling value of $16,584.13, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business serving as the sole regional prime vendor under PPV-G GEN V's single-award indefinite delivery contract (SPE2DX), which carries a $499.999 billion ceiling and runs through December 31, 2036. Place of performance is Park Ridge, Illinois. The order is priced on a firm fixed-price basis with an ultimate completion date of May 13, 2026.

Quick answers

Who was awarded contract SPE2DR26FQTC8?

SPE2DR26FQTC8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 22, 2026.

How much is contract SPE2DR26FQTC8 worth?

The government has obligated $16,584 on SPE2DR26FQTC8.

Is contract SPE2DR26FQTC8 an order under another contract?

Yes. SPE2DR26FQTC8 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.

Was contract SPE2DR26FQTC8 competed?

The extent of competition for SPE2DR26FQTC8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award